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Abstract 
Purpose of the review.  Use of illicit drug use before or during sex—known as sexualised drug use 
(colloquially ‘chemsex’ or ‘party and play’)—has evolved as novel psychoactive substances have 
entered the market in many parts of the world.  Here we review key conceptual issues in 
associations between illicit drug use and sexual risk behaviour in men who have sex with men 
(MSM). 
Recent findings.  Though many studies have confirmed that MSM use drugs with greater prevalence 
than the general population, evidence is of variable quality and a sampling frame is difficult to 
establish.  Moreover, psychosocial hypotheses linking drug use and sexual risk, including cognitive 
escape and sensation seeking, are unsatisfactory and generally ignore strategic use of drugs for 
sexual aims.  Person-level associations between drug use history and both sexual risk behaviour and 
HIV infection tend to be consistent around the world, but evidence comparing encounters within 
subjects is generally unclear and out of date.   
Summary.  There is a need for interventions for harm reduction targeted at MSM that account 
specifically for the social and cultural contexts of sexualised drug use.  Expanded attention to 
surveillance of emerging drug use trends can help clinicians in sexual health and infectious diseases 
best anticipate the needs of their service users. 
Keywords: men who have sex with men; illicit drug use; HIV infection; sexual risk behaviour 
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Introduction 
Cross-sectional prevalence studies from many countries have indicated that a higher proportion of 
men who have sex with men (MSM) utilise a range of illicit drugs than is the case among the general 
population (1-3), although establishing this difference conclusively is hampered by a lack of studies 
that consider both groups using the same methodology. Drug use is often culturally situated and can 
play an important function in the communities of gay and bisexual men who partly comprise the 
MSM behavioural category. Much of the literature on drug use among MSM has focussed on illicit 
substances used in ‘clubbing’, social environments. These include stimulants such as ecstasy or 
cocaine, or dissociatives such as ketamine, and have been collectively referred to as ‘club drugs’.  
As new psychoactive substances have entered the marketplace within MSM communities across the 
world, settings for drug use have changed as well. These newer drugs (including crystal 
methamphetamine, mephedrone and gamma-hydroxybutrate/gamma butralactone [GHB/GBL]), in 
addition to possessing similar stimulant properties to ecstasy and cocaine, also commonly have the 
effect of increasing sexual arousal. As a consequence, use of these drugs is more commonly 
associated with sex in private homes, or in the context of sex-on-premises venues, such as saunas or 
bath houses (4, 5). In much of western and central Europe, as well as parts of south Asia, this 
behaviour has become colloquially referred to as ‘chemsex’, while in North America and Australasia 
the term ‘party and play’ is more commonly utilised.  
In this review we focus specifically on illicit drug use among MSM and, therefore, exclude discussion 
of alcohol, or drugs which are commonly available on prescription, such as those that address 
erectile dysfunction (although, for a review of these issues, see Fisher et al(6)). We begin by outlining 
the extent of drug use, as understood in those countries where data relating to MSM is available, 
before exploring the explanations and motivations for using drug – particularly in sexual settings. 
This is followed by a conceptual review of the literature that describes associations between drug 
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use and sexual risk behaviour, as well with HIV and STI transmission. We close by considering 
priorities for future research. 
 
Prevalence of drug use among MSM 
The extent of drug use among MSM in most countries is difficult to determine. Sex between men 
remains illegal in 79 countries around the world, while political and cultural stigma also restricts the 
collection of data specific to this population. In a majority of countries, national drug surveillance 
systems do not collect or disaggregate data according to sexual orientation, meaning that estimates 
of drug use prevalence are largely reliant on community and clinical surveys of MSM. These are 
often subject to methodological limitations, including the lack of established sampling frame, 
limitations in the range of settings in which data is collected and varied time periods of reporting 
(e.g. drug use within the previous 24 hours, 7 days, 1 month, year, ever etc.). Those countries with 
the most robust, recent and national-level data include: Australia, where a cross sectional survey of 
MSM in three cities in 2011 identified drug use within the previous 6 months to include cocaine 
16.0%, crystal meth 10.0%, ketamine 7.5%, GHB 9.9% and ecstasy 25.7%(3), noting a significant 
decline in ecstasy and ketamine use over the previous seven years; Europe, where the European 
MSM Internet Study (EMIS)(7) of 2010 reports use of ‘party drugs’ (a combined measure of ecstasy, 
amphetamine, methamphetamines, GHB, ketamine and cocaine) within the previous 4 weeks to be 
highest (10.6%) among MSM in Western Europe (France, Republic of Ireland, the Netherlands, UK), 
followed by MSM in South western Europe (6.6%, Greece, Spain, Italy & Portugal); and Asia, where 
in the Asian MSM Internet Survey of 2010, a cross-sectional study of 10,861 MSM in 12 Asian 
countries, 16.7% of participants reported recreational drug use in the past 6 months, with ecstasy 
(8.1%) the most prevalent drug used(8). Among a cross-sectional sample of 625 MSM in Shenyang, 
China, 23.2% had ever used recreational drugs, with the most common illicit substances being 
methylmorphine phosphate (5.1%), methamphetamine (4.0%) and ketamine (0.8%)(9). Evidence of 
drug use prevalence in the United States is hard to determine at a total population level due to 
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state, city and sub-population sampling. In nearly all of the cited instances above, reports of illicit 
substances relate to use in general and are not specifically tied to use within sexual contexts, 
reflecting a significant shortcoming in the literature.  
In examining available data from across the globe, it is possible to say that most evidence supports 
the notion that drug use among MSM is generally episodic rather than continuous(7, 10) is a 
minority behaviour among the population of MSM, and is more common among MSM with 
diagnosed HIV (7, 8, 11). Trends in drug use among MSM are largely influenced by cultural forces, as 
well as legal or political restrictions and broader drug market economics (e.g. availability and quality 
of product). Historically, rates of injection drug use among MSM have been very low in nearly all 
reporting countries (with the exceptions of Tanzania(12) and Australia(13)), although there is 
emerging evidence to suggest this may be changing within a Western European context as newly 
popular drugs lend themselves to injection delivery (5, 14).  
 
Psychosocial hypotheses linking substance use and sexual risk behaviours 
Several psychosocial hypotheses associate substance use and risky sex, both specific to MSM and 
generally. One basic and intuitive explanation is myopia theory, which posits that the effect of 
substance use on cognitive functioning and the ability to foresee longer-term consequences is what 
increases the odds of risky behaviours(15). However, past reviews found inconsistent evidence 
across studies, almost all of which were laboratory experiments on samples of heterosexual college 
students(16). This disinhibitory process is what could be said to ‘cause’ sexual risk behaviour as a 
result of substance use(17). However, this explanation is neither complete nor able to account for 
the full complexity of linkages between substance use and risky sex, not least because without a 
randomised trial, a causal effect between substance use and sexual risk behaviour cannot be 
established(18). 
5 
 
A hypothesis developed specifically as regards substance use and HIV risk behaviour in MSM is 
‘cognitive escape’, which posits that substance use is a mechanism by which MSM can escape the 
rigorous norms governing gay sexuality in order to engage more freely in risky sexual behaviours(19, 
20). This includes expectancies of substance use and sexual disinhibition, which themselves are 
associated with sexual risk behaviour(21). The theory of ‘cognitive escape’ has some empirical 
support. A recent situational association study of a street-recruited sample of MSM in New York City 
found that the rate of UAI while under the influence of substances in the past three months was 
predicted by levels of cognitive escape and expectancies(22). 
Finally, an alternative explanation for the link between substance use and risky sex is ‘sensation 
seeking’, or the desire to pursue the most sensorily powerful sexual experiences(23). Though this 
theory is intended to have broad applicability, original measurement tools for sensation seeking 
were developed on samples of MSM(23). A recent review (18) observed that the evidence for the 
hypothesis in which sensation seeking has a main effect on sexual risk is mixed, possibly because of 
the importance of contextual and personality factors in determining risky sex behaviours—put 
otherwise, substance use and risky sex are not determined by each other, but by characteristics 
inherent in the person combining these two behaviours. 
Each of these explanations, however, ignores the role of substance use as a strategic resource in 
achieving sexual goals. A recently published study of ‘chemsex’ among MSM in the UK(5, 24) 
highlights the value MSM ascribe to drug use in sexual settings in terms of facilitating sexual self-
confidence or self-esteem, and in overcoming concerns relating to body image or sexual 
performance. MSM with diagnosed HIV in this study also commonly rationalised their use of drugs as 
providing an escape from concerns about rejection by sexual partners (following HIV status 
disclosure) or about accidental onward transmission. The use of mephedrone, GHB/GBL and, in 
particular, crystal methamphetamine – can facilitate a sense of sexual adventure(25), enabling men 
both cognitively and physically to engage in sexual practices they may otherwise have considered 
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taboo or unachievable (such as ano-brachial intercourse [‘fisting’], group sex or extended sexual 
sessions).  
 
Associations with HIV or other sexually transmitted infections 
As the developments in the prevention of HIV continue apace (largely owing to HIV treatments 
rendering HIV positive MSM uninfectious if used effectively (26, 27)), accurately determining the risk 
of transmission is complicated, but studies have tended towards conceptualising risk as unprotected 
anal intercourse with a casual and/or sero-discordant partner (or someone whose status you were 
unaware of). This is especially true in relation to STIs other than HIV.  
To understand links between substance use before sex and sexual risk behaviour, it is most helpful 
to examine specific sexual encounters(28).  A systematic review of encounter-level studies of 
substance use and sexual risk in MSM found inconsistent evidence for all associations except for 
those between crystal methamphetamine and UAI and between binge alcohol use and UAI(29).  
However, this encounter-level evidence is scant and, in the main, not up to date.  A recent 
encounter-level study(30) that compared sexual encounters within MSM using a sample recruited in 
the United States found that ‘club drugs’ (by the study definition, MDMA, ketamine and GHB) were 
associated with an almost 11-fold increase in the odds of unprotected anal intercourse, whereas 
‘methamphetamines’ (including both crystal meth and speed) were associated with a three-fold 
increase.  Encounter-level analyses on samples of MSM recruited in England who reported 
encounters with new partners showed associations between chemsex drugs (crystal 
methamphetamine, mephedrone, GHB or ketamine) and UAI, and between ‘uppers’ (MDMA, 
amphetamine or cocaine) and UAI(31).  This analysis also showed that while encounters in sex-on-
premises venues were associated with decreased risk of UAI as compared to encounters in private 
venues, in the presence of drug use before sex, sexual risk was elevated and similar across both sex-
on-premises venues and private venues.  In another encounter-level analysis, MSM living in England 
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reported that any drug use was associated with increased odds of UAI during group sex, with a 
three-fold increase in odds of UAI associated with use of crystal methamphetamine(31). 
Outside of the UK and the United States, the literature that illustrates the interaction between illicit 
drug use and sexual risk taking behaviour remains complex and incomplete. Subject to the same 
methodological limitations identified earlier, a sizeable number of studies have identified broad level 
associations between the use of illicit substances and increased likelihood of reporting HIV or STI 
transmission risk sexual behaviour(32-36). Similarly, studies in many countries have identified recent 
drug use as a factor correlated with HIV or STI infection (37-39).  
HIV/AIDS and substance use can be considered syndemic among MSM. Syndemics are two or more 
co-occurring epidemics in a population for which coexistence creates an interaction effect(40).  The 
conceptual nature of syndemic theory means that it is difficult to test as a causal model.  Yet cross-
sectional evidence consistently points to the association between several psychosocial health 
problems, including substance use, and HIV risk behaviours (41, 42).  In a community-based sample 
of young MSM in Chicago, substance use was found to be a key syndemic factor with intimate 
partner violence, HIV risk behaviours and HIV seropositive status(21). Similarly, in a community-
based sample of MSM in New York City, substance use, HIV-positive serostatus and sexual 
compulsivity were all significantly related to each other and all significantly predicted HIV risk 
behaviours, including UAI(43).  Most recently, Santos and colleagues observed syndemic 
relationships between substance use, HIV risk behaviours and HIV infection in a global sample of 
MSM(44). Hirshfield and colleagues(42) found syndemic relationships between drug use and HIV risk 
behaviour, including group sex encounters, in an online cross-sectional sample of MSM. Clearly, an 
avenue for further research includes investigating additional conditions and behaviours that play a 
part, alongside substance use and HIV risk behaviour in syndemic production. 
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Considering a sexualised drug use agenda 
While the last few years have seen widespread media and political concern relating to the role of 
illicit drug use among MSM in and how it may be contributing to rising STI and HIV incidence in many 
countries, there is currently limited evidence to support this assumption. That is not to say an 
association does not exist, but rather that previous research is insufficient to say with certainty. As 
the profile of drugs used has changed in many part of the world, methodological limitations 
alongside structural, political and legal barriers negatively impact our ability to fully understand and 
respond to drug use among this population.  
As the preceding discussion has demonstrated, there are many questions about drug use and sexual 
risk behaviour in MSM for which rigorous and relevant empirical evidence is lacking.  While the 
association between drug use and sexual risk behaviour at the person level is well established, 
epidemiological analysis of the association between drug use and sexual risk needs to examine 
encounter-level dynamics.  In particular, studies that seek to compare multiple encounters within 
persons, and that understand how these encounter-level associations are moderated by person-
level characteristics, are important to shape an effective public health response.  Moreover, there is 
a demonstrated need for estimates of prevalence of drug use, and of harms related to sexualised 
drug use, to better understand the scope of this phenomenon.  A related issue is improved 
measurement and consistency of terminology across studies when referring to specific drug 
exposures. 
Another key issue is the development of interventions that address specifically the contexts of drug 
use within which sexual risk occurs.  A systematic review of interventions for HIV risk reduction in 
drug-using MSM found that interventions were almost all ‘therapeutic’ in nature and did not seek to 
address episodic, rather than dependent, drug use(45).  However, several recent results have shown 
that counsellor-guided brief interventions may hold promise for HIV risk reduction in drug-using 
MSM.  Though the overall analysis did not show an effect, a subgroup analysis examining non-
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substance dependent MSM found that a personalised cognitive counselling intervention for HIV-
seronegative MSM reduced the risk of UAI with non-primary partners as compared to a testing-only 
control(46).  What is clear is that additional research is necessary to develop and refine interventions 
for reduction of both sexual and drug-related harms in MSM, especially when drug use is not in the 
context of dependence. 
 
Conclusion 
Health and social care professionals are tasked with keeping pace with changing trends in drug use 
across a demographically diverse, and often socially marginalised, population who have tended to 
use different drugs and in different contexts than the heterosexual population, using an evidence 
base that is incomplete. It is crucial that routine drug surveillance in every country take account of 
MSM, providing an evidence base on the extent of use, and that harm reduction research pay closer 
attention to the design and evaluation of interventions to support MSM in relation to their sexual 
health, and their broader well-being.  
 
Key points 
 Understanding the prevalence and patterns of drug use among MSM across the world is 
hampered by restrictive legal and cultural environments that discriminate against sexual 
minorities. 
 There are multiple motivations and explanations for using illicit drugs among MSM, which 
need to be understood when developing related sexual health and harm reduction services. 
 While there is a clear association between the use of drugs in general, and engagement in 
HIV or STI transmission risk behaviour, the current evidence of event-level interactions is 
insufficient to draw firm conclusions as to their impact.  
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